公司概覽
業務類別 Medical Instruments & Supplies
業務概覽 Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
公司地址 100 Matsonford Road, Suite 200, Building One, Radnor Corporate Center, Radnor, PA, USA, 19087
電話號碼 +1 610 386-1700
傳真號碼 +1 610 573-2650
公司網頁 https://www.avantorsciences.com
員工數量 13500
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. R. Brent Jones Executive Vice President and Chief Financial Officer 美元 653.27K 01/04/2026
Ms. Brittany Hankamer Executive Vice President and Chief Human Resources Officer -- 11/02/2026
Mr. Benoit Gourdier Executive Vice President, Bioscience and Medtech Products 美元 550.00K 23/04/2026
Mr. Corey Walker President, Laboratory Solutions 美元 700.00K 11/02/2026
Mr. Emmanuel Ligner President and Chief Executive Officer 美元 379.30K 27/03/2026
Mr. Steven W. Eck Senior Vice President and Chief Accounting Officer -- 01/04/2026
Mr. James Bramwell Executive Vice President, Sales and Customer Excellence -- 08/01/2025
Ms. Mary Blenn Executive Vice President and Chief Operating Officer -- 11/02/2026
Mr. Claudius Sokenu Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary 美元 550.00K 11/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Joseph R. Massaro Independent Director 27/03/2026
Mr. Gregory L. Summe Chairman of the Board 27/03/2026
Mr. Sanjeev K. Mehra Independent Director 27/03/2026
Dr. Michael Severino, M.D. Independent Director 27/03/2026
Mr. Simon P Dingemans Independent Director 27/03/2026
Mr. Juan Andres Independent Director 27/03/2026
Ms. Mala Murthy Independent Director 27/03/2026
Ms. Dame Louise Makin, D.B.E.,PhD Independent Director 27/03/2026
Ms. Lan Kang Independent Director 27/03/2026
Mr. John Carethers Independent Director 27/03/2026
Mr. Gregory T. Lucier Independent Director 27/03/2026
 
所屬ETF (更新日期: 02/05/2026 02:17)
代號 名稱 佔比% 持有日期
FTAFirst Trust Large Cap Val AlphaDEX® ETF<0.000001%07/10/2025
FXHFirst Trust Health Care AlphaDEX® ETF<0.000001%06/01/2026
HKNDHumankind US Stock ETF<0.000001%24/11/2025
HLALWahed FTSE USA Shariah ETF<0.000001%22/09/2025
HYTBlackRock Corp High Yield<0.000001%31/12/2025
ILCBiShares Morningstar U.S. Equity ETF<0.000001%05/03/2026
ILCViShares Morningstar Value ETF<0.000001%04/03/2026
IMCBiShares Morningstar Mid-Cap ETF<0.000001%06/03/2026
IMCViShares Morningstar Mid-Cap Value ETF<0.000001%05/03/2026
INROiShares U.S. Industry Rotation Act ETF<0.000001%05/03/2026
JHMLJHancock Multifactor Large Cap ETF<0.000001%16/03/2026
KOKUXtrackers MSCI Kokusai Equity ETF<0.000001%27/08/2025
LSEQHarbor Long-Short Equity ETF<0.000001%28/01/2026
MEDIHarbor Health Care ETF<0.000001%05/08/2025
NBCRNeuberger Core Equity ETF<0.000001%13/01/2026
NUMVNuveen ESG Mid-Cap Value ETF<0.000001%27/08/2025
NZACState Street®SPDR®MSCIACWIClmPrsAlgndETF<0.000001%27/08/2025
OMFLInvesco Russell 1000® Dynamic Mltfct ETF<0.000001%06/03/2026
PABUiShares Paris-Algnd Clmt Optd MSCIUSAETF<0.000001%04/03/2026
PBUSInvesco MSCI USA ETF<0.000001%27/08/2025
  1    2    3    4    5    6   7    8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.